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Abstract 
Aim 
Hypoxia causes vasodilatation of coronary arteries which protects the heart from ischaemic 
damage through mechanisms including the generation of hydrogen sulfide (H2S), but the 
influence of the perivascular adipose tissue (PVAT) and myocardium is incompletely 
understood. This study aimed to determine whether PVAT and the myocardium modulate the 
coronary artery hypoxic response, and whether this involves hydrogen sulfide.   
 
Methods 
Porcine left circumflex coronary arteries were prepared as cleaned segments and with PVAT 
intact, myocardium intact or both PVAT and myocardium intact, and contractility 
investigated using isometric recording. Immunoblotting was used to measure levels of H2S 
synthesizing enzymes: cystathionine-β-synthase (CBS), cystathionine -lyase (CSE) and 3-
mercaptopyruvate sulfurtransferase (MPST).  
 
Results All three H2S synthesizing enzymes were detected in the artery and myocardium, but 
only CBS and MPST were detected in PVAT. Hypoxia elicited a biphasic response in 
cleaned artery segments consisting of transient contraction followed by prolonged relaxation. 
In arteries with PVAT intact hypoxic contraction was attenuated and relaxation augmented. 
In arteries with myocardium intact hypoxic contraction was attenuated, but relaxation was 
unaffected. In replacement experiments, replacement of dissected PVAT and myocardium 
attenuated artery contraction and augmented relaxation to hypoxia, mimicking in situ PVAT 
and indicating involvement of a diffusible factor(s). In arteries with intact PVAT, 
augmentation of hypoxic relaxation was reversed by amino-oxyacetate (CBS inhibitor), but 
not DL-propargylglycine (CSE inhibitor) or aspartate (inhibits MPST pathway).  
 
Conclusion 
PVAT augments hypoxic relaxation of coronary arteries through a mechanism involving H2S 
and CBS, pointing to an important role in regulation of coronary blood flow during hypoxia.  
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Introduction 
In the heart, hypoxia which occurs as a consequence of ischaemia is a dangerous insult which 
compromises cardiac function. Coronary vasodilatation is an important physiological 
response to hypoxia that increases blood flow and, therefore, oxygenation to the hypoxic or 
ischaemic myocardium, but the mechanism is not fully defined. We and others have recently 
shown that hydrogen sulphide (H2S) (or other thiol-derived product) is a mediator of hypoxic 
relaxation in porcine coronary arteries,
1,2
 consistent with its suggested role as an oxygen 
sensor/transducer in the vasculature.
3,4
 We showed that this involves principally the H2S 
synthesizing enzyme cystathionine -synthase (CBS).2 This is important because 
cystathionine γ-lyase (CSE) is widely regarded as the principal H2S synthesising enzyme in 
the vasculature,
5
 and thus CBS emerges as a novel therapeutic target for treating ischaemic 
heart disease. These experiments were carried out in porcine coronary arteries that had been 
cleaned of their adherent perivascular adipose tissue (PVAT) and myocardium and the 
location of the CBS involved in hypoxic relaxation was identified as the vascular smooth 
muscle. The influence of the PVAT and myocardium on the hypoxic response of the 
vasculature is incompletely understood. 
 
PVAT is attracting increasing interest because of its role as a source of vasoactive factors.
6-12
 
We were interested in its contribution to vasomotor function during hypoxia in the heart 
because reduced oxygenation in ischemia would be expected to affect the adjacent fat and the 
myocardium as well. The interactions between the artery wall, PVAT and myocardium 
during hypoxia are poorly defined. In preliminary studies, we observed that when the PVAT 
surrounding coronary artery segments was left intact, hypoxic relaxation was augmented.
13
 In 
mouse aorta, PVAT similarly enhanced the hypoxic relaxation response, but the mediator 
involved was not identified.
14
 The objective of the present study was, therefore, to define the 
role of PVAT and myocardium in the hypoxic response of the coronary artery and to test the 
hypothesis that this involved H2S, since there is evidence that H2S can be released from 
adipocytes as a vasorelaxing factor.
15,16
 As a part of this investigation we sought to 
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specifically define which of the H2S-synthesizing enzymes, CBS, CSE and/or 3-
mercaptopyruvate sulfurtransferase (3-MST), was involved in the hypoxic production of H2S 
in the coronary artery by PVAT and/or myocardium. 
 
Results 
Effect of in situ PVAT and myocardium on the coronary artery response to hypoxia 
In the cleaned segments of porcine coronary artery (PVAT and myocardium removed), 
hypoxia (95 % N2, 5 % CO2; measured oxygen tension of 30 µM) caused a biphasic response 
consisting of an initial transient contraction, followed by a prolonged and pronounced 
vasorelaxation (Figure 1), as observed by us and others previously.
2,17
 When both PVAT and 
myocardium were left attached to the artery segments the hypoxic contraction was abolished 
and the relaxation was augmented, by more than 100 % (control 71.7 ± 5.6 %, with PVAT 
and myocardium 160.8 ± 15.3 %, n = 8; p < 0.001, paired t test) (Figure 1A-C). These 
changes were mimicked in vessels in which PVAT alone was left attached to the artery 
segments; here the hypoxic contraction was reduced and the relaxation was augmented 
(control 93.5 ± 7.2 %, with PVAT 123.9 ± 8.3 %, n = 8; p < 0.01, paired t test) (Figure 1D-
F). In vessels in which myocardium alone was left attached to the artery segments, the 
hypoxic contraction was also blunted, but the relaxation response was not significantly 
different to that in the controls (control 94.9 ± 12.7 %, with myocardium 96.0 ± 13.9 %, n = 
8; p > 0.05, paired t test) (Figure 1G-I). These data show that both PVAT and myocardium 
attenuate the coronary artery hypoxic contraction, but only PVAT augments the hypoxic 
relaxation.   
 
Data for the effects of the different experimental preparations (PVAT alone, myocardium 
alone, and myocardium plus PVAT) on contractility to U46619 and KCl, and on the 
concentration of U46619 used to achieve the required level of contractile tone, under 
normoxic conditions, are shown in Figure 2. U46619-induced tone was generally well 
controlled at ~50-60% of the contraction to KCl (Figure 2B), and the contraction to KCl was 
unaffected by the different experimental conditions (Figure 2C). Interestingly, the 
concentration of U46619 required to achieve this level of tone was greater in preparations 
with PVAT (PVAT alone and PVAT plus myocardium), consistent with an anticontractile 
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effect of PVAT (Figure 2A). Myocardium alone had no significant effect on either the 
concentration of U46619 or the level of tone. The effect of endothelium removal is shown for 
reference, and shows that a lower concentration of U46619 is needed to precontract the artery 
segments in the absence of endothelium (Figure 2A), consistent with the known 
anticontractile effect of the endothelium. Effects of the endothelium on the hypoxic response 
are considered in detail in our previous study.
2
     
 
Effect of replacing dissected PVAT and myocardium on the coronary artery response to 
hypoxia 
In order to investigate the possible involvement of a diffusible factor, replacement 
experiments were carried out where dissected PVAT and/or myocardium were placed 
adjacent to segments of cleaned porcine coronary artery segments (PVAT and myocardium 
removed) within the organ baths. The presence of both dissected PVAT and myocardium 
reduced the hypoxic contraction, although not significantly, and augmented the hypoxic 
relaxation of the coronary artery segments (control 75.5 ± 6.2 %, with added PVAT and 
myocardium 99.5 ± 4 %, n = 8; p < 0.001, paired t test) (Figure 3A,B), thus mimicking the in 
situ effects of PVAT and myocardium on the hypoxic response. The augmentation of the 
hypoxic relaxation was less pronounced than in the vessels with intact fat and myocardium 
(~25 % increase with replaced PVAT and myocardium versus >100% increase with in situ 
PVAT and myocardium) (compare Figures 1B and 3B). These data suggest the involvement 
of a diffusible factor released from PVAT and/or myocardium that can modulate the coronary 
artery response to hypoxia. Neither replacement of PVAT alone nor myocardium alone, 
however, mimicked the effects of replacing both PVAT and myocardium; replacement of 
PVAT alone caused a modest but significant increase in hypoxic contraction and attenuation 
of relaxation (Figure 3C,D); replacement of myocardium alone had no significant effect on 
either phase of the hypoxic response (Figure 3E,F).    
 
Effect of inhibitors of H2S synthesis on the response to hypoxia in coronary arteries 
The above experiments suggested that PVAT, but not myocardium, modulates the coronary 
artery hypoxic relaxation response and this involves the actions of a diffusible factor. 
Accordingly, we used artery segments with PVAT left intact to test the hypothesis that H2S 
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was involved, using inhibitors of CSE (PPG, 10 µM) and CBS (AOAA, 100 µM), and 
inhibition of the MPST pathway (aspartate, 1 mM). In arteries with intact PVAT the hypoxic 
contraction was attenuated and this effect was unaffected by CSE, CBS or MPST, applied 
alone or in combination (Figure 4A,B). In arteries with intact PVAT the coronary artery 
hypoxic relaxation was augmented and this effect was reversed by AOAA, which reduced the 
response ~50 % thus normalising the hypoxic response (control 69.1 ± 5 %, with PVAT 
103.5 ± 9.1 %, with PVAT plus AOAA 49.9 ± 6.6 %, n = 7-15; p < 0.05, ANOVA) (Figure 
4A,C). AOAA was similarly effective when applied alone or in combination with the other 
H2S enzyme inhibitors, although for some of the combinations the effect did not reach 
statistical significance (Figure 4C). In contrast, augmentation by PVAT of hypoxic relaxation 
was unaffected by either an inhibitor of CSE (PPG) or an inhibitor of the MPST pathway 
(aspartate), or by a combination of PPG and aspartate (Figure 4C). These data suggest that 
H2S or a thiol-derived product is released from PVAT during hypoxia to augment coronary 
artery hypoxic relaxation.  
 
Measurement of endogenous H2S levels and release in coronary arteries, PVAT and 
myocardium  
H2S levels in the extracellular space above homogenates from cleaned coronary arteries 
(without PVAT or myocardium), PVAT alone and myocardium alone, contained within 
sealed containers, was measured using a zinc trap method during conditions of hypoxia (95% 
N2, 5% CO2) and during gassing with oxygen (95% O2, 5% CO2). Gaseous H2S levels were, 
unexpectedly, lower under conditions of hypoxia than during gassing with oxygen, for both 
the porcine coronary arteries and PVAT (Figure 5B). Only for myocardium was the gaseous 
H2S greater under conditions of hypoxia than during gassing with oxygen (Figure 5B). 
Analysis of control samples (absence of tissue) showed an increase in H2S detected during 
gassing with oxygen compared to hypoxia (Figure 5C). Measurement of H2S levels in 
homogenates of porcine coronary arteries alone, PVAT alone and myocardium alone showed 
that the tissue levels were unchanged by the different gassing conditions (Figure 5A).  
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Expression of CSE, CBS and MPST in the porcine coronary artery and in its adjacent 
muscle and fat  
Using antibodies we have previously characterized for cross-reactivity with porcine 
enzymes,
18
 immunoblot analysis showed that all three enzymes CSE (44 kDa) (Figure 6), 
CBS (63 kDa) (Figure 7) and MPST (33 kDa) (Figure 8) are present within the porcine 
coronary artery (using actin (45 kDa) as a control to normalise for protein level variation) 
(n=4). All three enzymes were also present in the adjacent myocardium; expression levels of 
CSE in the myocardium (Figure 6) were lower than those of CBS and MPST (Figure 7 and 
8). CBS and MPST, but not CSE, were detected in the PVAT (Figure 6-8). These data are in 
line with our previous observations in the cleaned porcine coronary artery
2
 and extend the 
data to coronary artery PVAT and myocardium. 
 
Discussion 
The main finding of this study is that PVAT augments the hypoxic relaxation response of 
porcine coronary arteries through a mechanism which involves H2S. Contractility studies 
using inhibitors of the enzymatic synthesis of H2S showed that the most important enzyme 
responsible for H2S generation from coronary artery PVAT during hypoxia is CBS, and this 
correlates with the immunoblotting data which show that CBS and MPST, but not CSE, are 
the principal H2S synthesising enzymes expressed in coronary artery PVAT.  
 
The porcine coronary artery response to hypoxia consists of an initial transient contraction 
followed by a prolonged relaxation; the hypoxic contraction is endothelium dependent and 
involves NO and the relaxation is endothelium-independent.
2,17
 We have recently provided 
evidence that hypoxic relaxation of the porcine coronary artery involves H2S generated 
predominantly by CBS; in that study the PVAT and myocardium were dissected away and 
the source of the H2S mediating hypoxic relaxation was identified as the vascular smooth 
muscle.
2
 In the present study, we investigated the effect of leaving intact the adjacent PVAT 
and myocardium to mimic more closely the conditions experienced by the coronary artery in 
vivo. When PVAT and myocardium were both left intact, this abolished the hypoxic 
contraction and greatly augmented hypoxic relaxation of the coronary artery, by more than 
100 %. Leaving intact either PVAT, or myocardium, also attenuated the hypoxic contraction, 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
but only PVAT augmented the hypoxic relaxation. These data indicate that the coronary 
artery relaxation response to hypoxia can be profoundly increased by the adjacent PVAT. 
This is not simply due to an anticontractile effect of PVAT on hypoxic contraction, and 
consequent inhibition of the functional antagonism that contraction may have on hypoxic 
relaxation, because both PVAT and myocardium alone reduced the hypoxic contraction, but 
only PVAT augmented relaxation.  
 
In order to investigate whether these effects involved a diffusible factor we carried out 
replacement experiments where dissected PVAT and myocardium, separately or combined, 
were placed adjacent to the coronary artery in the organ baths. We found that replacement of 
PVAT and myocardium together mimicked the effect of leaving PVAT intact, and PVAT and 
myocardium together intact, on the hypoxic response; the hypoxic vasorelaxation was 
augmented and the hypoxic contraction was attenuated. This indicates the involvement of 
vasorelaxant/anticontractile factor(s) released from PVAT and/or myocardium during 
hypoxia. The changes seen with the replacement experiments, for both hypoxic contraction 
and relaxation, were smaller than those observed when PVAT and myocardium were left in 
situ, which is consistent with the involvement of a diffusible factor achieving different local 
concentrations at the artery under the two experimental conditions. Replacement experiments 
involving PVAT alone or myocardium alone did not mimic their in situ effects, or the effect 
or replacing PVAT together with myocardium, for reasons which are unclear.   
 
We and others have shown that H2S is an important mediator of the hypoxic vasorelaxant 
response of the coronary artery, in artery segments with their PVAT removed.
1,2
 In the 
present study, further studies were carried out to test its possible involvement as a diffusible 
factor released from PVAT. In vessels with intact PVAT, the augmentation of the coronary 
artery hypoxic relaxation was reversed by AOAA, normalising the hypoxic response and 
pointing to CBS as the enzyme involved in the generation of H2S by PVAT. AOAA was 
similarly effective when applied alone or in combination with the other inhibitors of the 
enzymatic synthesis of H2S (PPG and aspartate). In contrast, augmentation of hypoxic 
relaxation by PVAT was unaffected by an inhibitor of CSE (PPG) and inhibition of the 
MPST pathway (aspartate), or by their combination. As in PVAT, CBS also appears to be the 
most important enzyme involved in hypoxic generation of H2S by the coronary artery (in the 
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absence of PVAT and myocardium).
2
 It is unlikely that reversal by AOAA of the PVAT-
mediated augmented hypoxic relaxation is simply due to its attenuation of H2S produced by 
the coronary artery smooth muscle (and not H2S produced by PVAT), since AOAA at 100 
µM was ineffective against hypoxic relaxation of the cleaned coronary artery (absence of 
PVAT and myocardium),
2
 whereas in the present study it reduced the hypoxic relaxation in 
arteries with intact PVAT by ~50 % (Figure 4C).       
 
The hypoxic contraction of the porcine coronary artery without PVAT and myocardium is 
endothelium-dependent and a principal mechanism involved is the NO pathway.
2,17
 The 
present in situ experiments suggest that both PVAT and myocardium can attenuate the 
hypoxic contraction, and the replacement experiments identify the involvement of a diffusible 
factor. In arteries with PVAT intact the attenuated contraction was, interestingly, unaffected 
by inhibitors of CSE (PPG), CBS (AOAA) or of the MPST pathway (aspartate), applied 
alone or in combination (Figure 3B). The simplest explanation is that an anticontractile factor 
that is not H2S is involved in PVAT-mediated attenuation of hypoxic contraction of the 
coronary artery. Evaluation of its identity needs further experimentation and there are a 
number of possible candidates.
6-12 
In rat coronary arteries, cardiomyocyte-rich perivascular 
tissue had an anticontractile effect on agonist-induced contractions, which involved a 
reduction in Ca
2+
 sensitivity and was unaffected by the CSE inhibitor PPG.
19,20
 We found no 
anticontractile effect of myocardium on responses to U46619 under normoxic conditions, 
suggesting that there is no ongoing basal release of anticontractile factors from myocardium 
adjacent to the porcine coronary artery. This is in contrast to PVAT and endothelium, the 
presence of both of which was associated with an anticontractile effect as evidenced by the 
requirement of a lower concentration of U46619 to induce contractile tone. However, our 
data do suggest that hypoxia is a stimulus for the release of non-H2S anticontractile factors 
from myocardium. 
 
The concentrations of the inhibitors that we used (PPG, 10 µM; AOAA, 100 µM) are in line 
with their relative potencies at CSE and CBS respectively. AOAA has limited selectivity for 
CBS,
21,22
 however, since PPG had no effect on the hypoxic response this is unlikely to 
involve CSE. In addition, we have previously shown that AOAA, but not PPG, blocks 
pyridoxal phosphate-dependent generation of H2S from the porcine coronary artery.
2
 The 
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inhibitors were shown to have no effect on pinacidil induced relaxations of the porcine 
coronary artery.
2
 The augmented hypoxic relaxation that we have observed is thus likely to 
involve CBS-mediated generation of H2S by PVAT under hypoxic conditions, increasing the 
levels of H2S overall. The H2S then causes relaxation through a mechanism which may 
involve potassium channels and Cl
-
/HCO3
-
 exchange.
1,2,14,23
 Maenhaut et al. similarly 
suggested an involvement of potassium channels in the enhanced hypoxic vasorelaxation of 
mouse aortas with intact adipose tissue.
14
 Activation of potassium channels has been 
suggested to release H2S from PVAT as a relaxing factor in rodent mesenteric artery and 
aorta.
16
  
 
We investigated the effect of hypoxia on H2S levels measured in the space immediately 
above homogenates of porcine coronary arteries, PVAT and myocardium, in sealed 
Erlenmeyer flasks, using a zinc trap method.
24
 We detected an increase in gaseous H2S during 
hypoxia only for the myocardium. However, H2S levels measured in controls in the absence 
of tissue showed H2S levels to be greater during gassing with oxygen than during hypoxia for 
reasons which are not clear. This may have masked changes in H2S levels in the experiments 
using tissues. Our data suggest that H2S generated within the tissue during hypoxia does not 
accumulate in the extracellular space at levels sufficient for detection by the zinc trap 
method. Measurement of H2S levels in tissue homogenates showed no differences in H2S 
levels with gassing condition in the porcine coronary arteries, PVAT and myocardium.    
 
Immunoblotting was carried out to investigate which H2S synthesizing enzymes are involved 
in the hypoxic generation of H2S; this showed the presence of all three H2S-synthesizing 
enzymes, CBS, CSE and MPST, in the coronary artery, consistent with our previous 
immunoblotting and immunohistochemical studies.
2
 CBS, CSE and MPST were all also 
found to be expressed in the myocardium. However, only CBS and MPST were expressed in 
PVAT, in line with our functional studies pointing to an involvement of CBS in augmentation 
of hypoxic relaxation of the coronary artery by PVAT. In contrast, CSE is the main H2S-
synthesising enzyme in rat aortic PVAT and adipocytes of epididymal fat pads.
15,25
 Hypoxic 
relaxation of the rat thoracic aorta was essentially abolished by PPG,
3
 pointing to a 
predominant involvement of CSE and suggesting that there are pronounced tissue and/or 
species differences in the enzymes involved in hypoxic synthesis of H2S. Although the size 
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and arterial system of the porcine heart are very similar to that of humans,
26
 further 
investigations are warranted to understand whether the H2S system within the coronary 
vasculature and its PVAT is a therapeutic target in man.  
 
In conclusion, the present study has shown for the first time that the coronary artery hypoxic 
response is augmented by PVAT and this involves H2S generated by CBS. Our finding that 
H2S is an important endogenous mediator released during a hypoxic insult in the coronary 
vasculature is consistent with evidence in other blood vessels (rat aorta, lamprey and hagfish 
dorsal aorta, rat and bovine pulmonary arteries, perfused rat lung) that H2S acts as an oxygen 
sensor and transducer of the hypoxic response.
3,4,27,28
 We have recently suggested that CBS 
may be a novel therapeutic target for the treatment of heart failure;
2
 the present study 
reinforces this and identifies the cellular location of this target (CBS) as PVAT as well as the 
vascular smooth muscle. 
 
Materials and methods 
Tissue preparation 
Pig hearts (either sex, age less than 6 months, weighing ∼50 kg) were obtained on ice from a 
local abattoir (G Wood & Sons Ltd, Mansfield, UK). The left circumflex coronary artery was 
crudely dissected and stored overnight at 4 °C in gassed (95 % O2, 5 % CO2) Krebs-Henseleit 
solution as previously described.
2,29
 After allowing time for equilibration to room 
temperature, coronary arteries were either: a) finely dissected to remove surrounding tissue, 
b) dissected with fat attached to the vessel, c) dissected with muscle attached to the vessel, or 
d) dissected with both fat and muscle attached to the vessel. Arteries were then cut into rings 
of ~5 mm (internal diameter ~2-3 mm) and suspended between two wires before transfer to 
organ baths containing gassed (95% O2, 5% CO2) Krebs’-Henseleit solution. In some 
experiments, PVAT, myocardium, or both PVAT and myocardium were finely dissected out 
from the porcine coronary arteries and then were threaded onto the same wires used to 
suspend the porcine coronary artery segments, to investigate the possible involvement of a 
diffusible factor. The endothelium was left intact in all artery segments except for some of the 
data in Figure 2, where indicated; here the endothelium was removed by gentle rubbing as 
previously described.
2
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Responses in the porcine isolated coronary artery 
Arterial rings were mounted onto wires in 20 ml tissue baths. Each ring was attached to an 
isometric force transducer (ADInstruments, Sydney, Australia) which was connected to a 
Powerlab (ADInstruments). Tension changes were captured by a computer running LabChart 
software (ADInstruments). The arterial rings were tensioned to ~10 g and allowed to 
equilibrate for 60 min. The viability of the tissue was assessed using 60 mM KCl. Once a 
reproducible response to KCl was achieved (2-3 additions) and the tissue had returned to 
baseline tension, the thromboxane A2 analogue U46619 (11α,9α-epoxymethano-PGH2) was 
added in a cumulative manner to contract the vessels to ~50-60 % of the final KCl response.  
 
Experimental protocols 
Once an appropriate level of U46619 induced contraction had been achieved, the vessels 
were exposed to hypoxia by switching the gas to 95% N2/ 5% CO2 for 30 min. The roles of 
PVAT and myocardium as modulators of the contraction and relaxation response of porcine 
coronary arteries under hypoxic conditions were examined in the presence or absence of 
PVAT and myocardium as described above. To define if H2S-synthesizing enzymes were 
involved in the hypoxic production of H2S in the porcine coronary arteries by PVAT and/or 
myocardium, the effects of the CSE inhibitor DL-propargylglycine (PPG, 10 µM), CBS 
inhibitor amino-oxyacetate (AOAA, 100 µM) and MPST pathway inhibitor (1 mM aspartate; 
inhibits cysteine aminotransferase activity) alone or in combination were examined. All 
inhibitors were added before the addition of U46619, and thus were in contact with the tissue 
for at least 1 hour prior to hypoxia.  
 
Immunoblotting 
Coronary arteries were fine dissected and then segments were immediately frozen on dry ice. 
The segments were then homogenized in lysis buffer (20 mM Tris, 1 mM EGTA, 320 mM 
sucrose, 0.1% (v/v) Triton X-100, 1 mM NaF, 10 mM β-glycerophosphate, pH 7.6), 
containing protease inhibitor cocktail tablets (EDTA free). Once homogenised, the protein 
concentration in each of the samples was measured using the Bradford method and 
normalised. Samples, with solubilization buffer 6 × SB (24% (w/v) SDS, 30% (v/v) glycerol, 
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5% (v/v) β-mercaptoethanol, 2.5% (v/v) bromophenol blue, 1.5 M Tris–HCl, pH 6.8), were 
heated at 95 °C for 5 min. Subsequently, electrophoresis was carried out on 4–20% Tris-
glycine (PAGE) Gold Precast Gels (Bio-Rad, Hercules, CA, USA) with 5 μg protein per lane. 
Samples were transferred to nitrocellulose membranes, which were incubated in blocking 
solution (6% fish skin gelatin in Tris-buffered saline containing 0.1% (v/v) Tween 20) for 60 
min at room temperature. Blots were incubated overnight at 4 °C with primary antibody (1 µl 
per 500 ml MPST, 1.5 µl CBS/CSE in 500 ml) diluted in blocking solution. We used 
antibodies previously characterised for cross-reactivity with porcine enzymes with further 
validation using omission of primary antibody.
2,18
 After washing in Tris-buffered saline 
containing 0.1% (v/v) Tween 20, the blots were incubated with an appropriate IRDye®-
conjugated secondary antibody (Li-Cor Biosciences, Biotechnology, Lincoln, NE, USA). 
Proteins were visualized using the Li-Cor/Odyssey infrared imaging system.  
 
Endogenous H2S Production Assays  
The enzyme activity of endogenous H2S production in porcine coronary arteries, PVAT and 
myocardium was determine using the methylene blue method adapted from.
24
 Segments of 
finely dissected porcine coronary arteries (10% wt/vol), PVAT (14% wt/vol) or myocardium 
(14% wt/vol) were homogenized in ice-cold Tris-EDTA buffer (0.1 M, 1 mM, pH 7.4) using 
Precellys 24 homogenizer (Bertin Technologies, Stretton, Derbyshire) for porcine coronary 
arteries and Ultra-turrax homogenizer (Janke & Kunkel IKA-Werke GmbH & Co, Staufen, 
Germany) for PVAT and myocardium. Homogenate was then centrifuged at 3000 rpm for 5 
min at 4°C. To examine the H2S production in the tissue homogenates, the supernatant layer 
was removed and incubated with 100 mM L-cysteine and 100 µM pyridoxal phosphate. 2.5 
ml of the supernatant was then placed in a 50 ml Erlenmeyer flask and was flushed with 
either 95% O2/5% CO2 or 95% N2/5% CO2 for 10 min. A piece of filter paper (1.5 x 1.5 cm) 
soaked with zinc acetate was suspended on top of the sealed flask using a string. The flasks 
were then incubated at 37°C for 90 min with gentle shaking in a water bath to allow trapping 
of the H2S released. The presence of H2S produced was detected using colorimetric change 
method (0.1% (w/v) dimethylphenylene-diamine sulphate (DMPD) in 5 M HCl and 50 mM 
FeCl3). To examine the amount of gaseous H2S produced by the supernatant, the filter paper 
was placed into a 1.5 ml Eppendorf incubated with 200 µl of zinc acetate for 15 min. 500 µl 
of DMPD/ FeCl3 was then added into the Eppendorf and left for a further 20 min. In 
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triplicates, 200 µl of the mixtures were pipette into a 96-well plate. To assess the amount of 
H2S generated in the homogenate, again in triplicates, 10 µl of homogenate was incubated 
with 40 µl of zinc acetate and 150 µl of DMPD/ FeCl3 in a 96-well plate for 20 min. Samples 
were then analysed at the absorbance of 670 nm on a spectrometer. Concentrations of the H2S 
generated were extrapolated from a standard curve obtained using Na2S (0 – 80 µM). Data 
are expressed as picomoles per mg of protein. 
 
Data analysis 
Hypoxic responses were measured in grams (g) and plotted against time from which area 
under the curve data were generated. The contractile and relaxation phases of the hypoxic 
response were expressed as a percentage of the U46619 response. Values for all figures refer 
to mean ± SEM and data were assessed for statistical significance via Student’s t-test or one-
way ANOVA with Tukey’s post-test (GraphPad Prism 6, San Diego, CA, USA). Differences 
were considered to be significant when the P-value was <0.05, where n is the number of 
animals. 
 
Materials  
Krebs–Henseleit buffer (mM); NaCl 118, KCl 4.8, CaCl2·H2O 1.3, NaHCO3 25.0, KH2PO4 
1.2, MgSO4·1.2 and glucose 11.1 (Fisher, Loughborough). U46619 (Tocris Bioscience, 
Bristol) was dissolved in ethanol at 10 mM stock concentration, then further diluted to 10 µM 
in distilled water. Stock solutions of PPG, AOAA and aspartate (Sigma, Poole Dorset) were 
prepared in distilled water. Primary antibodies for Western blotting were purchased from; 
CSE, AbCam (Cambridge, UK), CBS, Abnova (Jhongli, Taiwan), MPST and actin, Sigma 
(Dorset, UK).  
 
Funding 
This project was funded by the British Heart Foundation (PG/11/45/28975). 
 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
Conflict of interest 
None 
 
References  
1. Hedegaard ER, Nielsen BD, Kun A, Hughes AD, Krøigaard C, Mogensen S, Matchkov 
VV, Fröbert O, Simonsen U. KV7 channels are involved in hypoxia-induced vasodilatation 
of porcine coronary arteries. Br J Pharmacol, 171: 69-82, 2014.  
2. Donovan J, Wong PS, Roberts R, Garle MJ, Alexander SPH, Dunn WR, Ralevic V. A 
critical role for cystathionine-β-synthase in hydrogen sulfide-mediated hypoxic relaxation of 
the coronary artery. Vascular Pharmacol, 93-95: 20-32, 2017.  
3. Olson KR, Dombkowski RA, Russell MJ, Doellman MM, Head SK, Whitfield NL, 
Madden JA. Hydrogen sulfide as an oxygen sensor/transducer in vertebrate hypoxic 
vasoconstriction and hypoxic vasodilation. J Exp Biol, 209(20): 4011-4023, 2006. 
4. Olson KR. Hydrogen sulfide as an oxygen sensor. Antioxid Redox Signal, 22: 377-397, 
2015.  
5. Dunn WR, Alexander SPH, Ralevic V, Roberts R. Effects of hydrogen sulfide in smooth 
muscle. Pharmacology and Therapeutics, 158: 101-13, 2016. 
6. Gao YJ. Dual modulation of vascular function by perivascular adipose tissue and its 
potential correlation with adiposity/lipoatrophy-related vascular dysfunction. Curr Pharm 
Res, 13(21): 2185-2192, 2007. 
7. Maenhaut N, van de Voorde J. Regulation of vascular tone by adipocytes. BMC Mecicine, 
9: 25, 2011. 
8. Aghamohammadzadeh R, Withers S, Lynch F, Greenstein A, Malik R, Heagerty A. 
Perivascular adipose tissue from human systemic and coronary vessels: the emergence of a 
new pharmacotherapeutic target. Br J Pharmacol, 165: 670-682, 2012. 
9. Gollasch M. Vasodilator signals from perivascular adipose tissue. Br J Pharmacol, 165, 
633-642, 2012. 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
10. Gollasch M. Adipose-vascular coupling and potential therapeutics. Ann Rev Pharmacol 
Toxicol, 57: 417–436, 2017. 
11. Brown NK, Zhou Z, Zhang J, Zeng R, Wu J, Witzman DT, Chen YE, Chang L. 
Perivascular adipose tissue in vascular function and disease. Arterioscler Thromb Vasc Biol, 
34: 1621-1630, 2014. 
12. Xia N, Li H. The role of perivascular adipose tissue in obesity-induced vascular 
dysfunction. Br J Pharmacol, 174(20): 3425-3442, 2017.  
13. Donovan J, Garle M, Alexander S, Dunn W, Ralevic V. Perivascular adipose tissue 
derived hydrogen sulphide contributes to hypoxic relaxation of the porcine coronary artery. 
Nitric Oxide, 47: S27, 2015. 
14. Maenhaut N, Boydens C, van de Voorde J. Hypoxia enhances the relaxing influence of 
perivascular adipose tissue in isolated mice aorta. Eur J Pharmacol, 641: 207-212, 2010.  
15. Fang L, Jing Z, Yu C, Tiemin M, Guoheng X, Chaoshu T, Xinmin L, Bin G. 
Hydrogen sulfide derived from periadventitial adipose tissue is a vasodilator. J Hypertension, 
27(11): 2174-2185, 2009. 
16. Schleifenbaum J, Köhn C, Voblova N, Dubrovska G, Zavarirskaya O, Gloe T, Crean CS, 
Luft FC, Huang Y, Schubert R, Gollasch M. Systemic peripheral artery relaxation by KCNQ 
channel openers and hydrogen sulphide. J Hypertension, 28(9): 1875-1882, 2010. 
17. Mellemkjaer S, Nielsen-Kudsk JE. Glibenclamide inhibits hypoxic relaxation of isolated 
porcine coronary arteries under conditions of impaired glycolysis. Eur J Pharmacol, 270: 307-
312, 1994. 
18. Rashid S, Heer JK, Garle MJ, Alexander SPH, Roberts RE. Hydrogen sulphide-induced 
relaxation of porcine peripheral bronchioles. Br J Pharmacol, 168: 1902-1910, 2013.  
19. Aalbaek F, Bonde L, Kim S, Boedtkjer E. Perivascular tissue inhibits rho-kinase-
dependent smooth muscle Ca(2+) sensitivity and endothelium-dependent H2S signalling in 
rat coronary arteries. J Physiol, 593(21): 4747-4764, 2015.  
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
20. Bonde L, Shokouh P, Jeppesen PB, Boedtkjer E. Crosstalk between cardiomyocyte-rich 
perivascular tissue and coronary arteries is reduced in the Zucker Diabetic Fatty rat model of 
type 2 diabetes mellitus. Acta Physiol, 219(1): 227-238, 2017. 
21. Asimakopoulou A, Panopoulos P, Chasapis CT, Coletta C, Zhou Z, Cirino G, Giannis A, 
Szabo C, Spyroulias GA, Papapetropoulos A. Selectivity of commonly used pharmacological 
inhibitors for cystathionine -synthase (CBS) and cystathionine  lyase (CSE). Br J 
Pharmacol, 169: 922-932, 2013. 
22. Papapetropoulos A, Whiteman M, Cirino G. Pharmacological tools for hydrogen sulphide 
research: a brief, introductory guide for beginners. Br J Pharmacol, 172: 1633-1637, 2015.  
23. Morales-Cano D, Moreno L, Barreira B, Pandolfi R, Chamorro V, Jimenez R, Villamor 
E, Duarte J, Perez-Vizcaino F, Cogolludo A. Kv7 channels critically determine coronary 
artery reactivity: left-right differences and down-regulation by hyperglycaemia. Cardiovasc 
Res, 106(1): 98-108 2015.  
24. Morikawa T, Kajimura M, Nakamura T, Hishiki T, Nakanishi T, Yukutake Y, Nagahata 
Y, Ishikawa M, Hattori K, Takenouchi T, Takahashi T, Ishii I, Matsubara K, Kabe Y, 
Uchiyama S, Nagata E, Gadalla MM, Snyder SH, Suematsu M. Hypoxic regulation of the 
cerebral microcirculation is mediated by a carbon monoxide-sensitive hydrogen sulfide 
pathway. Proc Natl Acad Sci USA, 109: 1293-1298, 2012. 
25. Feng X, Chen Y, Zhao J, Tang C, Jiang Z, Geng B. Hydrogen sulfide from adipose tissue 
is a novel insulin resistance regulator. Biochem Biophys Res Commun, 380: 153-159, 2009. 
26. Swindle MM, Makin A, Herron AJ, Clubb FJ, Frazier KS. Swine as models in 
biochemical research and toxicology testing. Vet Pathol, 49(2): 344-356, 2011. 
27. Olson KR, Forgan LG, Dombkowski RA, Forster ME. Oxygen dependency of hydrogen 
sulfide-mediated vasoconstriction in cyclostome aortas. J Exp Biol, 211: 2205-2213, 2008. 
28. Madden JA, Ahlf SB, Dantuma MW, Olson KR, and Roerig DL. Precursors and 
inhibitors of hydrogen sulfide synthesis affect acute hypoxic pulmonary vasoconstriction in 
the intact lung. J Appl Physiol, 112: 411–418, 2012. 
A
cc
ep
te
d 
A
rt
ic
le
 
This article is protected by copyright. All rights reserved. 
29. Rayment SJ, Latif ML, Ralevic V, Alexander SPH. Evidence for the expression of 
multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in 
porcine isolated arteries. Br J Pharmacol, 150: 604-612, 2007. 
 
Figure legends 
Figure 1 
Porcine coronary artery biphasic response to hypoxia and the effect of leaving intact the 
perivascular adipose tissue (PVAT) and myocardium. Coronary arteries were prepared with 
PVAT and myocardium removed (control), with PVAT and myocardium left intact (A-C), 
with PVAT intact (D-F), and with myocardium intact (G-I) and the effect of hypoxia (95 % 
N2, 5 % CO2) was investigated after pre-contraction of the arteries with the thromboxane A2 
receptor agonist U46619. Hypoxia elicited a biphasic response: contractions are shown in A, 
D and G; relaxations are shown in B, E and H; representative traces are shown in C, F and I. 
Hypoxic contraction was attenuated under all experimental conditions (when both 
myocardium and PVAT were left intact, and when PVAT and myocardium alone were left 
intact). Hypoxic relaxation was augmented when both myocardium plus PVAT were left 
intact, and with PVAT intact, but not when myocardium alone was left intact. N = 8. Data 
shown are mean ± s.e.mean. * P<0.05, paired t test.  
 
Figure 2 
Effect of different preparations of porcine coronary artery segments on contractions to 
U46619 and KCl (60 mM) and on the concentration of U46619 used to achieve the required 
contractile tone (of about 50-60% of the KCl response). Coronary artery segments were 
prepared with perivascular adipose tissue (PVAT) alone, myocardium alone, with both 
myocardium and PVAT, and without endothelium. A, Concentration of U46619; B, 
Contractile tone achieved; C, Contraction to KCl. Data were analysed using Student’s t test, 
where data from the different preparations are compared to their respective controls (n = 8). 
Data shown are mean ± s.e.mean. * P < 0.05.    
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Figure 3 
Porcine coronary artery biphasic response to hypoxia and the effect of replacing dissected 
perivascular adipose tissue (PVAT) and myocardium. Coronary arteries were prepared with 
PVAT and myocardium removed (control), with replacement of PVAT and myocardium (A, 
B), with replacement of PVAT (C, D), and with replacement of myocardium (E, F) and the 
effect of hypoxia (95 % N2, 5 % CO2) was investigated after pre-contraction of the arteries 
with the thromboxane A2 receptor agonist U46619. The replacement of both myocardium and 
PVAT augmented the hypoxic relaxation, but effects of replacement of either myocardium 
alone or PVAT alone had little or no effect (n = 8). Data shown are mean ± s.e.mean. * 
P<0.05, paired t test. 
 
Figure 4 
Porcine coronary artery biphasic response to hypoxia and the effect of leaving intact the 
perivascular adipose tissue (PVAT) and inhibition of hydrogen sulfide synthesis. Coronary 
arteries were prepared with PVAT and myocardium removed (control) and with PVAT intact 
and the effect of hypoxia (95 % N2, 5 % CO2) was investigated after pre-contraction of the 
arteries with the thromboxane A2 receptor agonist U46619. (A) Representative trace showing 
that the contractile response to hypoxia is attenuated and the relaxant response augmented in 
arteries with intact PVAT, and the reversal of the PVAT-mediated augmentation of relaxation 
by AOAA (100 µM; CBS inhibitor). (B) The attenuated contraction was unaffected by 
inhibitors of the enzymatic synthesis of H2S (PPG, 10 µM, AOAA, 100 µM, aspartate, 1 
mM), alone or in combination. (C) The augmented relaxant response to hypoxia in arteries 
with intact PVAT was reversed by the CBS inhibitor inhibitor AOAA, applied alone or in 
combination with other inhibitors of the enzymatic synthesis of H2S, but was unaffected by 
PPG and aspartate, inhibitors of CSE and the MPST pathway, respectively. Data shown are 
mean ± s.e.mean. n = 7-15. * P<0.05, ANOVA. 
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Figure 5 
Measurement of endogenous H2S levels and release in porcine coronary arteries, PVAT and 
myocardium. (A) Measurement of H2S levels in homogenates of porcine coronary arteries, 
PVAT and myocardium (n = 5-6). (B) H2S levels in the extracellular space above cleaned 
coronary arteries, PVAT alone and myocardium alone, measured using a zinc trap method 
during conditions of hypoxia (95% N2, 5% CO2) and during gassing with oxygen (95% O2, 
5% CO2) (n = 4-5). (C) Analysis of H2S levels in control samples (absence of tissue) during 
gassing with oxygen and hypoxia (n = 4).  
 
Figure 6 
Immunoblot analysis of porcine coronary artery, myocardium and perivascular adipose tissue 
(PVAT) (n=4) shows expression of CSE (44 kDa) within the porcine coronary artery and 
myocardium, but not in PVAT. Samples were the same as used for CBS immunoblotting, 
with the same loading; actin (45 kDa) levels used to indicate the level of protein are from 
Figure 7. 
 
Figure 7 
Immunoblot analysis of porcine coronary artery, myocardium and perivascular adipose tissue 
(PVAT) (n=4) shows expression of CBS (63 kDa) within the porcine coronary artery, 
myocardium and PVAT. Actin (45 kDa) was used to indicate the level of protein. 
 
Figure 8 
Immunoblot analysis of porcine coronary artery, myocardium and perivascular adipose tissue 
(PVAT) (n=4) shows expression of MPST (33 kDa) within the porcine coronary artery, 
myocardium and PVAT. Actin (45 kDa) was used to indicate the level of protein. Lane 5 in 
each blot is a liver sample. 
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